A detailed history of Optima Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Optima Capital LLC holds 340 shares of BMY stock, worth $15,915. This represents 0.01% of its overall portfolio holdings.

Number of Shares
340
Holding current value
$15,915
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 23, 2026

BUY
$42.6 - $49.08 $14,484 - $16,687
340 New
340 $18.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Optima Capital LLC Portfolio

Follow Optima Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optima Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optima Capital LLC with notifications on news.